These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 25913935)

  • 1. Discovery of Metal Ions Chelator Quercetin Derivatives with Potent Anti-HCV Activities.
    Zhong D; Liu M; Cao Y; Zhu Y; Bian S; Zhou J; Wu F; Ryu KC; Zhou L; Ye D
    Molecules; 2015 Apr; 20(4):6978-99. PubMed ID: 25913935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3-O-arylmethylgalangin, a novel isostere for anti-HCV 1,3-diketoacids (DKAs).
    Lee HS; Park KS; Lee B; Kim DE; Chong Y
    Bioorg Med Chem; 2010 Nov; 18(21):7331-7. PubMed ID: 20888241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of N-arylalkyl-3-hydroxy-4-oxo-3,4-dihydroquinazolin-2-carboxamide derivatives as HCV NS5B polymerase inhibitors.
    Deore RR; Chen GS; Chang PT; Chern TR; Lai SY; Chuang MH; Lin JH; Kung FL; Chen CS; Chiou CT; Chern JW
    ChemMedChem; 2012 May; 7(5):850-60. PubMed ID: 22383290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2-(2-Thienyl)-5,6-dihydroxy-4-carboxypyrimidines as inhibitors of the hepatitis C virus NS5B polymerase: discovery, SAR, modeling, and mutagenesis.
    Koch U; Attenni B; Malancona S; Colarusso S; Conte I; Di Filippo M; Harper S; Pacini B; Giomini C; Thomas S; Incitti I; Tomei L; De Francesco R; Altamura S; Matassa VG; Narjes F
    J Med Chem; 2006 Mar; 49(5):1693-705. PubMed ID: 16509585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel Guanosine Derivatives as Anti-HCV NS5b Polymerase: A QSAR and Molecular Docking Study.
    Elfiky AA
    Med Chem; 2019; 15(2):130-137. PubMed ID: 30324891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-hepatitis-C virus activity and QSAR study of certain thiazolidinone and thiazolotriazine derivatives as potential NS5B polymerase inhibitors.
    Hassan GS; Georgey HH; Mohammed EZ; Omar FA
    Eur J Med Chem; 2019 Dec; 184():111747. PubMed ID: 31604164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of Novel 3-Hydroxyquinazoline-2,4(1
    Cao Y; Aimaiti A; Zhu Z; Zhou L; Ye D
    Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and SAR optimization of diketo acid pharmacophore for HCV NS5B polymerase inhibition.
    Bhatt A; Gurukumar KR; Basu A; Patel MR; Kaushik-Basu N; Talele TT
    Eur J Med Chem; 2011 Oct; 46(10):5138-45. PubMed ID: 21893371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-nucleoside inhibitors of the hepatitis C virus NS5B RNA-dependant RNA polymerase: 2-aryl-3-heteroaryl-1,3-thiazolidin-4-one derivatives.
    Rawal RK; Katti SB; Kaushik-Basu N; Arora P; Pan Z
    Bioorg Med Chem Lett; 2008 Dec; 18(23):6110-4. PubMed ID: 18947995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel 4-thiazolidinones as non-nucleoside inhibitors of hepatitis C virus NS5B RNA-dependent RNA polymerase.
    Çakir G; Küçükgüzel İ; Guhamazumder R; Tatar E; Manvar D; Basu A; Patel BA; Zia J; Talele TT; Kaushik-Basu N
    Arch Pharm (Weinheim); 2015 Jan; 348(1):10-22. PubMed ID: 25449674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular design and synthesis of HCV inhibitors based on thiazolone scaffold.
    Al-Ansary GH; Ismail MA; Abou El Ella DA; Eid S; Abouzid KA
    Eur J Med Chem; 2013 Oct; 68():19-32. PubMed ID: 23933047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2-Heteroarylimino-5-arylidene-4-thiazolidinones as a new class of non-nucleoside inhibitors of HCV NS5B polymerase.
    Küçükgüzel I; Satılmış G; Gurukumar KR; Basu A; Tatar E; Nichols DB; Talele TT; Kaushik-Basu N
    Eur J Med Chem; 2013 Nov; 69():931-41. PubMed ID: 24161679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and antiviral properties of novel tetracyclic nucleoside inhibitors of hepatitis C NS5B polymerase.
    Di Francesco ME; Avolio S; Dessole G; Koch U; Pompei M; Pucci V; Rowley M; Summa V
    Nucleosides Nucleotides Nucleic Acids; 2012; 31(8):592-607. PubMed ID: 22908950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic potential of Taraxacum officinale against HCV NS5B polymerase: In-vitro and In silico study.
    Rehman S; Ijaz B; Fatima N; Muhammad SA; Riazuddin S
    Biomed Pharmacother; 2016 Oct; 83():881-891. PubMed ID: 27513212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of anthranilic acid derivatives as a novel class of allosteric inhibitors of hepatitis C NS5B polymerase.
    Nittoli T; Curran K; Insaf S; DiGrandi M; Orlowski M; Chopra R; Agarwal A; Howe AY; Prashad A; Floyd MB; Johnson B; Sutherland A; Wheless K; Feld B; O'Connell J; Mansour TS; Bloom J
    J Med Chem; 2007 May; 50(9):2108-16. PubMed ID: 17402724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a Pyridoxine-Derived Small-Molecule Inhibitor Targeting Dengue Virus RNA-Dependent RNA Polymerase.
    Xu HT; Colby-Germinario SP; Hassounah S; Quashie PK; Han Y; Oliveira M; Stranix BR; Wainberg MA
    Antimicrob Agents Chemother; 2016 Jan; 60(1):600-8. PubMed ID: 26574011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemical genetics-based discovery of indole derivatives as HCV NS5B polymerase inhibitors.
    Jin G; Lee S; Choi M; Son S; Kim GW; Oh JW; Lee C; Lee K
    Eur J Med Chem; 2014 Mar; 75():413-25. PubMed ID: 24561671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of Novel Thiophene-Based, Thumb Pocket 2 Allosteric Inhibitors of the Hepatitis C NS5B Polymerase with Improved Potency and Physicochemical Profiles.
    Court JJ; Poisson C; Ardzinski A; Bilimoria D; Chan L; Chandupatla K; Chauret N; Collier PN; Das SK; Denis F; Dorsch W; Iyer G; Lauffer D; L'Heureux L; Li P; Luisi BS; Mani N; Nanthakumar S; Nicolas O; Rao BG; Ronkin S; Selliah S; Shawgo RS; Tang Q; Waal ND; Yannopoulos CG; Green J
    J Med Chem; 2016 Jul; 59(13):6293-302. PubMed ID: 27366941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pyridobenzothiazole derivatives as new chemotype targeting the HCV NS5B polymerase.
    Manfroni G; Meschini F; Barreca ML; Leyssen P; Samuele A; Iraci N; Sabatini S; Massari S; Maga G; Neyts J; Cecchetti V
    Bioorg Med Chem; 2012 Jan; 20(2):866-76. PubMed ID: 22197397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular design, synthesis and cell based HCV replicon assay of novel benzoxazole derivatives.
    Ismail MA; Adel M; Ismail NS; Abouzid KA
    Drug Res (Stuttg); 2013 Mar; 63(3):109-20. PubMed ID: 23444170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.